Kris Thielemans focuses on Antigen, Immunology, Antigen presentation, Dendritic cell and Cytotoxic T cell. His Antigen research is multidisciplinary, incorporating elements of Molecular biology, Virology, Immune system and Cancer immunotherapy. Kris Thielemans interconnects Cell and Interleukin 12 in the investigation of issues within Immunology.
His Antigen presentation research incorporates elements of Priming, Human leukocyte antigen, Follicular dendritic cells, Major histocompatibility complex and Tumor antigen. His research integrates issues of CD40, T cell, Antigen-presenting cell, Monocyte and Cell biology in his study of Dendritic cell. His Cytotoxic T cell study incorporates themes from Immunoglobulin light chain, CD3, Melanoma and Vaccination.
Immunology, Antigen, Immunotherapy, Cancer research and Immune system are his primary areas of study. His study brings together the fields of Cytotoxic T cell and Immunology. The various areas that he examines in his Antigen study include Molecular biology, Tumor antigen and Cancer immunotherapy.
Within one scientific family, Kris Thielemans focuses on topics pertaining to Vaccination under Immunotherapy, and may sometimes address concerns connected to Oncology. Kris Thielemans has researched Immune system in several fields, including Ex vivo and In vivo. His research in Dendritic cell intersects with topics in Interleukin, Antigen-presenting cell, Monocyte and Cell biology.
His primary scientific interests are in Immunology, Immunotherapy, Cancer research, Immune system and Antigen. His work on T cell is typically connected to Myeloid-derived Suppressor Cell as part of general Immunology study, connecting several disciplines of science. His Immunotherapy study integrates concerns from other disciplines, such as Cytotoxic T cell, Dendritic cell and Transfection.
His work is dedicated to discovering how Dendritic cell, Cell biology are connected with Antigen presentation, IL-2 receptor and Electroporation and other disciplines. His Immune system research includes elements of Autologous stem-cell transplantation, Multiple myeloma and Vaccination. As a member of one scientific family, Kris Thielemans mostly works in the field of Antigen, focusing on Virus and, on occasion, DNA vaccination.
The scientist’s investigation covers issues in Immunology, Immune system, Immunotherapy, Antigen and T cell. Kris Thielemans works in the field of Immunology, namely Cancer immunotherapy. His study looks at the intersection of Immune system and topics like In vivo with CD3 and Angiogenesis.
His study in Immunotherapy is interdisciplinary in nature, drawing from both Dendritic cell and Transfection. Many of his studies on Antigen apply to Cancer research as well. His T cell research integrates issues from Cytotoxic T cell, CD40 and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo
Roberto Maldonado-López;Thibaut De Smedt;Patrick Michel;Jacques Godfroid.
Journal of Experimental Medicine (1999)
Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
H. Cave;J. Van Der Werff Ten Bosch;S. Suciu;C. Guidal.
The New England Journal of Medicine (1998)
Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation
Bart N. Lambrecht;Marijke De Veerman;Anthony J. Coyle;Jose-Carlos Gutierrez-Ramos.
Journal of Clinical Investigation (2000)
Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells
Corine H. GeurtsvanKessel;Monique A.M. Willart;Leonie S. van Rijt;Femke Muskens.
Journal of Experimental Medicine (2008)
Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation
M. H. C. Bakkus;C. Heirman;I. Van Riet;B. Van Camp.
The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.
Hilde Van de Velde;Ilka von Hoegen;Wei Luo;Jane R. Parnes.
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.
VéRonique Flamand;Thierry Sornasse;Kris Thielemans;Christian Demanet.
European Journal of Immunology (1994)
B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo: Increased Interleukin 12 Production by DCs from B Cell–Deficient Mice Results in T Helper Cell Type 1 Deviation
Véronique Moulin;Fabienne Andris;Kris M. Thielemans;Charles Maliszewski.
Journal of Experimental Medicine (2000)
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor
Christel Buelens;Valérie Verhasselt;Donat De Groote;Kris M. Thielemans.
European Journal of Immunology (1997)
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes
Pascal Chaux;Valérie Vantomme;Vincent Stroobant;Kris Thielemans.
Journal of Experimental Medicine (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: